-
 Re: Kraig Biocraft Laboratories Inc. - KBLB
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Dividend Distributed to E*Trade Customers Ahead of Ex-Dividend Date
Kraig Biocraft Laboratories, Inc. informed its shareholders that E*Trade customers who purchased the company’s common stock prior to today have received the recently announced dividend, even though the ex-dividend date is not until Monday of next week. According to the press release, anyone who sells their shares before the dividend date will not receive the dividend.
The company apologized for the inconvenience and told investors to call 1-800-387-2331 if they have questions concerning the issue.
-
Kraig Biocraft Laboratories Inc. (KBLB.OB): Scientists Discover Method to Significantly Enhance Spider Silk Strength
Kraig Biocraft Laboratories, Inc. announced this afternoon that scientists have discovered a way to increase the strength of spider silk three-fold by adding small amounts of metal. Even though the spider-made fiber is already tougher and lighter than steel, this new technique could make it useful for manufacturing super-tough textiles and high-tech medical materials.
The discovery was made by researcher Seung-Mo Lee of the Max Planck Institute of Microstructure Physics in Halle, Germany. Lee and his colleagues used a process called atomic layer deposition, which not only coated spider dragline silks with metal but also caused some metal ions to penetrate the fibers and react with their protein structure.
According to the press release, the discovery was based on the observation that some insects have traces of metals in their toughest body parts. For example, the jaws of leaf-cutter ants and locusts contain high levels of zinc, making them particularly stiff and hard.
“This new discovery is absolutely incredible,” commented CEO Kim Thompson. “Spider silk is already known as one of the strongest fibers found in nature and is recognized for its unparalleled capacity to absorb and dissipate energy in a very controlled manner. Being five times stronger than steel of the same diameter in its natural form, this enhancement reminds us again of the extraordinary potential spider silk has. Kraig Biocraft Laboratories is committed to continuing to develop sustainable spider silk for commercial use worldwide.”
-
Re
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Taps Universities to Maximize Success
Kraig Biocraft Laboratories, Inc., a biotechnology development company focused on genetically engineered high performance polymers and technical fibers, has managed to significantly leverage its efforts and success through cooperative work with select university laboratories. It’s a creative arrangement, under the Kraig Research Initiative, that allows Kraig to bring technologies from diverse research institutions and combine them. As part of the program, Kraig licenses university intellectual property in genetics and genetic engineering, tapping some of the greatest minds in the field.
Based on proprietary genetic engineering technology, Kraig is working to develop and produce polymers and protein-based materials, including spider silk. The company believes that spider silk is a “super fiber” that will have numerous commercial and consumer applications. In fact, the spider silk gene sequences, at the core of the technology, were first studied and patented by Dr. Lewis of the University of Wyoming. In 2006, Kraig obtained exclusive rights from the University for certain uses of the sequences.
Kraig is using genetic engineering to coax silkworms into producing spider silk. To do this, scientists had to develop the technology to successfully insert into silkworms the DNA packets containing the unique gene sequence used by spiders to produce silk. Since Kraig Biocraft first obtained the right to use the spider silk gene sequence, they have surprised many with the progress they’ve made, performing thousands of insertions in a single week. Scientists working in the company’s research program at the University of Notre Dame continue to make substantial progress in the successful insertion of DNA packets, increasing both the number and proportion of insertions. As their success with insertions increases, so does their chance of developing a viable polymer.
There’s good reason for Kraig Biocraft to do everything they can to leverage their efforts to develop high performance polymers and fibers. Emerging Growth Research, an independent California based industry research firm, stated recently that, should Kraig achieve its goal, “the technology will likely immediately be worth at least several hundred million dollars”.
-
Re
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Prepares to Insert Successfully Created Genetic Constructs
Kraig Biocraft Laboratories, Inc. announced that Dr. Malcolm Fraser, Dr. Wang, Dr. Sohn and other members of the scientific team are preparing for the genetic insertion of recently created DNA constructs. The genetic constructs are customized packets of DNA that provide genetic instructions for the creation of new polymers and spider silk-based proteins. These unique genetic insertion packets include several that are specifically designed for the production of new fusion silk proteins.
CEO Kim K. Thompson stated, “These constructs include a number of new DNA combinations that are truly exciting. The increases in laboratory productivity over the last eight months are now enabling us to do more and to do it faster. This number of unique genetic constructs is a new breakthrough for the Company. Each of these constructs has the potential to result in the development of a new polymer or high performance fiber.”
Over the past year, the University of Notre Dame added Dr. Wang, Dr. Sohn and other scientists to the research team. Since that time, Kraig Biocraft has seen a dramatic increase in both the quality and quantity of the work performed. According to Dr. Fraser, the team is ready to ramp up their effort to insert as many constructs as possible.
-
Re
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Developing Next Generation “Super Fiber” from Spider Silk
Kraig Biocraft Laboratories, Inc., an emerging biotech company, is focused on developing the most advanced insect-related genetic engineering techniques to produce spider silk – one of the strongest and most resilient fibers known to mankind.
Spider silk is extremely strong. In fact, studies have shown that spider silk is at least five times stronger than steel of the same diameter. Spider silk is also able to absorb enormous amounts of energy prior to breakage, making it a “super fiber” that can support many ballistic resistant, medical, fashion and industrial applications.
The worldwide market for these fibers and other high-performance technical fibers is currently estimated at approximately $90 billion per year, with the United States accounting for more than half of the market. The market has experienced significant growth over the past 10 years, and is expected to maintain its momentum over the coming years.
-
Re
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Prepares to Substantially Increase the Number of Genetic Insertions Performed
Kraig Biocraft Laboratories, Inc. announced this morning that the scientific team is preparing to significantly increase the number of genetic insertions performed in the month of May. The team believes that the rate of DNA construct insertions in May will be twice the number that has been performed to date. Every targeted insertion has the potential to create a new recombinant fiber with commercial applications.
“We are now entering the next phase in which the team is reallocating recourses to genetic insertion,” stated CEO Kim Thompson. “This is directly related to our recent development of new DNA constructs that are specifically targeted for the production of new fusion silk proteins. We intend to dramatically ramp up the number of insertions performed in order to gain the maximum benefit from the new insertion packets.”
Kraig Biocraft is committed to developing and commercializing high performance polymers using spider silk gene sequences. The company aims to tap into the $92 billion market for high performance and technical fibers. Since Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame in 2007, the company has been a proud sponsor of scientific research and development within the university.
-
Re
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Makes Great Strides
Kraig Biocraft Laboratories, Inc. is a young company that was founded by the inventor of the company’s technology and its current CEO, Kim Thompson. Mr. Thompson devised the idea for using silkworms to produce unique proteins that could be sold into both the technical textile and pharmaceutical industries. Should he be successful in this endeavor, it is widely believed that he will be considered one of the great geniuses of the biotech industry.
One of the keys to the company’s success will be spider silk. The marketplace has asked the question, what is so exciting about spider silk? The answer is rather complex but may revolutionize the biotech industry. The silk produced by spiders is among the strongest fibers produced in nature. It is also extremely elastic and resilient. Depending upon how measurements are made, spider silk is stronger than Kevlar or steel.
One of the significant properties of spider silk, however, is its extreme resistance to breaking under strain. Relative to this property, spider silk significantly outperforms virtually all known natural and synthetic fibers. It is this property that makes spider silk particularly appealing for use as a “super fiber”.
As of late, Kraig Biocraft has been rising up the charts on Wall Street. Currently, the company is a fully reporting organization and there are approximately 50 million common shares outstanding, with approximately 64% of these being held by the chief executive officer.
-
Re
Kraig Biocraft Laboratories Inc. (KBLB.OB) and Team of Scientists Successful in Creating 8 Spider Silk-Based DNA Constructs
Kraig Biocraft Laboratories Inc. develops protein-based fiber using recombinant DNA technology. The company uses spider silk because of its exceptional strength and durability. Some spiders produce up to seven different types of silk, depending on its use, for catching prey, spinning a web, or traveling.
Since spiders are cannibals and hard to keep in colonies, the company maintains its focus on reproducing the fibers, mimicking nature as much as it can. The fibers can be used in military and police departments, industrial and consumer applications, as well as for the aero-space industry.
Earlier this month, Kraig Biocraft announced that it, along with a team of scientists, successfully created eight DNA constructs, which they plan on using for genetic insertion in the upcoming weeks. Having teamed up with the University of Notre Dame to move into the $92 billion market for technical fibers, the news is a milestone for the company and the university.
“These constructs include a number of new DNA combinations that are truly exciting,” said CEO Kim K. Thompson. “The increases in laboratory productivity over the last eight months are now enabling us to do more and to do it faster. This number of unique genetic constructs is a new breakthrough for the company. Each of these constructs has the potential to result in the development of a new polymer or high performance fiber.”
In layman’s terms, the genetic constructs are packets of DNA that act as a blueprint for the creation of new polymers and spider silk-based proteins. According to the company and participating scientists, the experiments have dramatically increased, and the team plans on accelerating its efforts to create more constructs.
-
Re
Kraig Biocraft Laboratories, Inc.’s (KBLB.OB) Focus on High Performance Fibers and Polymers
Kraig Biocraft Laboratories Inc. is a company focused on the development of high performance technical fibers and polymers utilizing spider genes which are inserted into silkworms. The company aims to create a transgenic variety of silkworms capable of spinning a new “super fiber” that is similar to natural spider silk, one of the strongest and most resilient fibers known.
While the production of a “super fiber” is Kraig Biocraft’s primary focus, the company is also considering the production of other unique proteins utilizing transgenic silkworms as a protein expression platform. It is thought that there is a large, viable market for these unique proteins in the pharmaceutical and biotechnology industries, among others.
Kraig Biocraft has acquired the exclusive rights, in their field of use, to use the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is also working in conjunction with leading genetic engineers at these universities in creating these unique fibers and proteins.
As part of the company’s intellectual property portfolio, Kraig Biocraft has the exclusive rights to use the patented spider silk gene sequences in silkworms within the US. The company’s intellectual property portfolio also includes a separate US provisional patent application regarding certain methodologies, genetic sequences, organic polymers and composites of fibers. The company expects their intellectual property portfolio to continue to grow over the coming years.
-
Re
Kraig Biocraft Laboratories, Inc. (KBLB.OB) is on the Verge of Unlocking Exciting Technology
We have been covering Kraig Biocraft Laboratories since December of last year. Those who have read our articles understand why we are excited about this company’s prospects to develop a “super fiber” that can be sold into the technical textiles industry. This super fiber, spider silk, has truly remarkable properties and may have numerous commercial and consumer applications.
Currently Kraig Biocraft is in the research and development stage, but has been making excellent progress in the labs and is now capable of accomplishing five thousand genetic transfers in a single week using its newly designed DNA insertion packets. Additional lab personnel and a change in techniques has significantly boosted productivity and the company’s odds of success.
Artificial or transgenic production of spider silk will surely be viewed by the scientific community as a major breakthrough. Such a development would also likely yield significant coverage in the general business and popular press sectors, perhaps offering Kraig Biocraft Laboratories significant public relations exposure, which could easily drive its market value to much higher levels.
Once achieving a major breakthrough in the laboratory, it could take Kraig Biocraft awhile to completely refine the process. It is anticipated that the company’s management team would actively pursue licensing agreements or the outright sale of the company during this time. Should the company make a breakthrough, we believe it would be unlikely that the company would actually produce the fibers on its own as this would require very specialized management skills and extensive amounts of fresh capital. An acquisition would be much more likely.
|
Checking For Related Data... |
View Profile
View Forum Posts
Private Message
Visit Homepage
Reply With Quote
Posting Permissions
Bookmarks